Characterization of Biomarkers to Immune Checkpoint Inhibitor Therapy in Solid Tumors

被引：0
|
作者：
Huang, Xiu [1 ]
Russell, Meaghan K. [1 ]
Pantazi, Angeliki [2 ]
Lvova, Maria [1 ]
Vuzman, Dana [1 ]
Lyle, Stephen [3 ]
Tse, Julie Y. [4 ]
机构：
[1] KEW Inc, Cambridge, MA USA
[2] KEW Inc, Lethbridge, AB, Canada
[3] Univ Massachusetts, Worcester, MA 01605 USA
[4] KEW Inc, Tufts Med Ctr, Boston, MA USA
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1950
引用
收藏
页码：701 / 701
页数：1
相关论文
共 50 条
  • [21] Cardiac Surveillance in Immune Checkpoint Inhibitor Therapy Biomarkers Versus Imaging
    Vallejo-Camazon, Nuria
    Delgado, Victoria
    JACC: CARDIOONCOLOGY, 2022, 4 (05): : 686 - 688
  • [22] Clinically relevant prognostic biomarkers for immune checkpoint inhibitor therapy in NSCLC
    Zeitler, Gloria
    Brueckl, Wolfgang
    Ficker, Joachim
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 16 - 16
  • [23] The other immuno-PET: Metabolic tracers in evaluation of immune responses to immune checkpoint inhibitor therapy for solid tumors
    Levi, Jelena
    Song, Hong
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [24] Genomic characterization of immune checkpoint inhibitor resistance genes and hyperprogression genes in advanced solid tumors.
    Xu, Libin
    Zhang, Ge
    Mu, Tianhao
    Wang, Zhizheng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors
    Pender, Alexandra
    Titmuss, Emma
    Pleasance, Erin D.
    Fan, Kevin Y.
    Pearson, Hillary
    Brown, Scott D.
    Grisdale, Cameron J.
    Topham, James T.
    Shen, Yaoqing
    Bonakdar, Melika
    Taylor, Gregory A.
    Williamson, Laura M.
    Mungall, Karen L.
    Chuah, Eric
    Mungall, Andrew J.
    Moore, Richard A.
    Lavoie, Jean-Michel
    Yip, Stephen
    Lim, Howard
    Renouf, Daniel J.
    Sun, Sophie
    Holt, Robert A.
    Jones, Steven J. M.
    Marra, Marco A.
    Laskin, Janessa
    CLINICAL CANCER RESEARCH, 2021, 27 (01) : 202 - 212
  • [26] Histopathologic Characterization of Myocarditis Associated With Immune Checkpoint Inhibitor Therapy
    Sobol, Irina
    Chen, Carol L.
    Mahmood, Syed S.
    Borczuk, Alain C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (11) : 1392 - 1396
  • [27] New biomarkers for checkpoint inhibitor therapy
    Burdett, Nikki
    Desai, Jayesh
    ESMO OPEN, 2020, 5
  • [28] B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors
    Flippot, Ronan
    Teixeira, Marcus
    Rey-Cardenas, Macarena
    Carril-Ajuria, Lucia
    Rainho, Larissa
    Naoun, Natacha
    Jouniaux, Jean-Mehdi
    Boselli, Lisa
    Naigeon, Marie
    Danlos, Francois-Xavier
    Escudier, Bernard
    Scoazec, Jean-Yves
    Cassard, Lydie
    Albiges, Laurence
    Chaput, Nathalie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [29] The efficacy and safety of solid tumors combination therapy with immune checkpoint inhibitor: A systematic review and meta-analysis
    Peng, M.
    Weng, Y.
    Yao, Y.
    Song, Q.
    ANNALS OF ONCOLOGY, 2018, 29
  • [30] The Efficacy and Safety of Solid Tumors Combination Therapy with Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis
    Peng, M.
    Weng, Y.
    Yao, Y.
    Song, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S928 - S929
12345